Veracyte, Inc.
NASDAQ:VCYT
32.92 (USD) • At close September 13, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Veracyte, Inc. |
Symbool | VCYT |
Munteenheid | USD |
Prijs | 32.92 |
Beurswaarde | 2,528,654,332 |
Dividendpercentage | 0% |
52-weken bereik | 18.61 - 33.33 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Marc A. Stapley |
Website | https://www.veracyte.com |
An error occurred while fetching data.
Over Veracyte, Inc.
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)